Company / Free Cash Flow
ACCENDRA HEALTH INC/VA/ Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$292.7M
FY2025
5-year range
-$292.7M / $568.3M
FY2021-FY2025
Trend
-3230.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow changed -3230% YoY in FY2025, a notable deviation from the 9-year average annual change of -297%.
Based on SEC 10-K filings.
-$293M in FY2025.
Declined from $568M to -$293M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 3230.1% year-over-year.
- Peak free cash flow was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$292.7M | -3230.1% |
| FY2024 | -$8.8M | -101.5% |
| FY2023 | $568.3M | +240.5% |
| FY2022 | $166.9M | +35.0% |
| FY2021 | $123.7M | -57.2% |
| FY2020 | $288.8M | +308.4% |
| FY2019 | $70.7M | +0.0% |
| FY2018 | $70.7M | +219.1% |
| FY2017 | $22.2M | -86.8% |
| FY2016 | $167.4M | -33.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026